Oskar Ragnarsson

Goeteborg, O, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 162 publications

Primary Aldosteronism Medical Treatment Outcomes (PAMO) Beyond 12 Months.

Primary Aldosteronism Medical Treatment Outcomes (PAMO) Beyond 12 Months.

Journal: Hypertension (Dallas, Tex. : 1979)

Published: July 22, 2026

Natural history of conservatively managed nonfunctioning pituitary macroadenomas in the elderly: A study from the Swedish Pituitary Registry.

Natural history of conservatively managed nonfunctioning pituitary macroadenomas in the elderly: A study from the Swedish Pituitary Registry.

Journal: Pituitary

Published: June 19, 2026

Cardiovascular morbidity and mortality in acromegaly-associated diabetes: a Swedish Nationwide study.

Cardiovascular morbidity and mortality in acromegaly-associated diabetes: a Swedish Nationwide study.

Journal: The Journal of clinical endocrinology and metabolism

Published: May 19, 2026

Postoperative changes in circulating brain injury biomarkers in relation to long-term fatigue and cognitive outcomes after surgery for nonfunctioning pituitary adenomas.

Postoperative changes in circulating brain injury biomarkers in relation to long-term fatigue and cognitive outcomes after surgery for nonfunctioning pituitary adenomas.

Journal: Pituitary

Published: April 27, 2026

Exploring epigenome-proteome interactions underlying post-surgical progression of non-functioning pituitary adenomas using hypernetwork modelling.

Exploring epigenome-proteome interactions underlying post-surgical progression of non-functioning pituitary adenomas using hypernetwork modelling.

Journal: Journal of translational medicine

Published: April 27, 2026

Prevalence of sick leave before and after pituitary adenoma surgery.

Prevalence of sick leave before and after pituitary adenoma surgery.

Journal: European journal of endocrinology

Published: April 02, 2026

Supraphysiological Glucocorticoid Doses and Pitfalls of Annual Biomarker Monitoring in Adults With CAH.

Supraphysiological Glucocorticoid Doses and Pitfalls of Annual Biomarker Monitoring in Adults With CAH.

Journal: Clinical endocrinology

Published: February 12, 2026

Quality of life in primary aldosteronism, medical vs surgical treatment: a systematic review and meta-analysis.

Quality of life in primary aldosteronism, medical vs surgical treatment: a systematic review and meta-analysis.

Journal: Journal of endocrinological investigation

Published: February 11, 2026

Cardiovascular and metabolic outcomes of GH replacement therapy in adults with GH deficiency - gender gaps.

Cardiovascular and metabolic outcomes of GH replacement therapy in adults with GH deficiency - gender gaps.

Journal: Pituitary

Published: December 17, 2025

Proteomic insights into the invasiveness and tumor progression of non-functioning pituitary adenomas: A scoping review.

Proteomic insights into the invasiveness and tumor progression of non-functioning pituitary adenomas: A scoping review.

Journal: Journal of neuroendocrinology

Published: December 15, 2025

Prevalence, risk factors and management of bone complications in Cushing`s syndrome across Europe. Data from the European Registry on Cushing's syndrome (ERCUSYN).

Prevalence, risk factors and management of bone complications in Cushing`s syndrome across Europe. Data from the European Registry on Cushing's syndrome (ERCUSYN).

Journal: Annales d'endocrinologie

Published: December 11, 2025

Prevalence, risk factors and management of bone complications in Cushing's syndrome across Europe. Data from the European Registry on Cushing's syndrome (ERCUSYN).

Prevalence, risk factors and management of bone complications in Cushing's syndrome across Europe. Data from the European Registry on Cushing's syndrome (ERCUSYN).

Journal: Annales d'endocrinologie

Published: December 11, 2025

Showing 1-12 of 162

Last Updated: 09/26/2026